David D. O'Toole - 12 Jun 2026 Form 4/A - Amendment Insider Report for AVITA Medical, Inc. (RCEL)

Reporting relationship: CFO
Issuer ticker: RCEL
Reported as of: 12 Jun 2026
Net transaction value: +$7,940
SEC form: 4/A - Amendment
Accepted by SEC: 24 Aug 2026, 17:00:26 UTC
Original report date: 12 Jun 2026
Prior SEC filing: 01 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ David O'Toole

Key filing fact

David D. O'Toole filed Form 4/A - Amendment for AVITA Medical, Inc. (RCEL) on 24 Aug 2026.

Key facts

This page summarizes David D. O'Toole's Form 4/A - Amendment filing for AVITA Medical, Inc. (RCEL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Aug 2026, 17:00.

Change

Previous filing in this sequence was filed on 01 Jun 2026.
Current net transaction value: +$7,940.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001491140 Primary reporting owner

O'Toole David D

Relationship: CFO
Address: 28159 AVENUE STANFORD, SUITE 220 - AVITA MEDICAL, VALENCIA
Signature: /s/ David O'Toole
Signature date: 24 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RCEL transaction

Common Stock

Purchase

Transaction value: $7,940
Shares: +2,000
Change %: +1.3%
Price: $3.97
Shares after: 152,927
Date: 12 Jun 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The original Form 4, filed on June 12, 2026, inadvertently used transaction code 'A' instead of transaction code 'P'. This amendment corrects the transaction code.

Footnote F2

Includes unvested RSUs